Evolution of Real-World Blood-Based Biomarker Use in the Lecanemab Patient Pathway: Three-Year Update From the LEADER Study
Copies of these presentations obtained through the QR code are for personal use only and may not be used without permission from AAIC and the authors of this presentation.
